Skip links
OncoOne

Maroua Ferhat, PhD was promoted to Senior Scientist

We are thrilled to announce that Maroua Ferhat, PhD has been awarded the promotion to Senior Scientist effective March 1, 2023 Maroua has been with the company for a year and a half and has progressively taken on more responsibility in our biology group, where

Promotion of Maria Reitzinger to Head of Finance and Administration

We are pleased to announce the promotion of Maria Reitzinger to Head of Finance and Administration, effective March 1, 2023. Maria joined OncoOne in June 2020 as an Executive Assistant and has taken on increasing responsibilities over the past two years. She has a professional background

OncoOne Newsletter Q4/2022

“In the fourth quarter of 2022, we traveled around the world sharing our message about the potential of oxMIF as an immuno-oncology and inflammation target. With our Series B raise underway and completion of several value-building projects I value this opportunity to update you on

J.P. Morgan Conference, January 9–12, 2023, San Francisco, CA, US

OncoOne’s CEO, Randolf Kerschbaumer, and CBO, Brent Meadows will be attending the 41st annual J.P. Morgan Conference in San Francisco, January 9-12, 2023. Reserve a spot to speak with our management team about the recent developments of our corporate agenda and how we are preparing

Festival of Biologics, November 2–4, 2022, Basel, CH

Our Scientist Maroua Ferhat will attend the Festival of Biologics in Basel, Switzerland. Be sure to visit her talk on ON104, our Novel Bioengineered Monoclonal Antibody Targeting Oxidized Macrophage Migration Inhibitory Factor (oxMIF) in autoimmune disorders.